Thrivent Financial For Lutherans Neurocrine Biosciences Inc Transaction History

Thrivent Financial For Lutherans

  • $51.6 Billion
  • Q4 2024

A detailed history of Thrivent Financial For Lutherans transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 737,772 shares of NBIX stock, worth $84.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
737,772
Previous 25,802 2759.36%
Holding current value
$84.3 Million
Previous $2.97 Million 3287.32%
% of portfolio
0.2%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$111.62 - $139.44 $79.5 Million - $99.3 Million
711,970 Added 2759.36%
737,772 $101 Million
Q3 2024

Nov 07, 2024
SELL
$114.58 - $153.15 $2.38 Million - $3.18 Million
-20,775 Reduced 44.6%
25,802 $2.97 Million
Q2 2024

Aug 13, 2024
BUY
$130.86 - $143.19 $2.83 Million - $3.1 Million
21,641 Added 86.79%
46,577 $6.41 Million
Q1 2024

May 14, 2024
BUY
$130.4 - $143.74 $50,986 - $56,202
391 Added 1.59%
24,936 $3.44 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $9,970 - $12,479
94 Added 0.38%
24,545 $3.23 Million
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $69,010 - $85,951
-734 Reduced 2.91%
24,451 $2.75 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $27,306 - $31,985
-305 Reduced 1.2%
25,185 $2.38 Million
Q1 2023

May 17, 2023
SELL
$94.11 - $123.02 $450,034 - $588,281
-4,782 Reduced 15.8%
25,490 $2.58 Million
Q4 2022

Feb 08, 2023
BUY
$106.72 - $127.06 $529,224 - $630,090
4,959 Added 19.59%
30,272 $3.62 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $21,903 - $25,658
238 Added 0.95%
25,313 $2.69 Million
Q2 2022

Aug 16, 2022
BUY
$75.79 - $100.07 $21,600 - $28,519
285 Added 1.15%
25,075 $2.44 Million
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $16,228 - $21,237
-224 Reduced 0.9%
24,790 $2.32 Million
Q4 2021

Feb 16, 2022
BUY
$79.65 - $106.22 $21,903 - $29,210
275 Added 1.11%
25,014 $2.13 Million
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $31,024 - $35,650
-360 Reduced 1.43%
24,739 $2.37 Million
Q2 2021

Aug 19, 2021
BUY
$89.43 - $102.27 $11,089 - $12,681
124 Added 0.5%
25,099 $2.44 Million
Q1 2021

May 17, 2021
BUY
$87.57 - $119.4 $2.19 Million - $2.98 Million
24,975 New
24,975 $2.43 Million
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $3.1 Million - $3.86 Million
-35,625 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$96.16 - $135.15 $18.5 Million - $26 Million
-192,400 Reduced 84.38%
35,625 $3.43 Million
Q2 2020

Aug 12, 2020
BUY
$85.09 - $130.36 $91,471 - $140,137
1,075 Added 0.47%
228,025 $27.8 Million
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $3,680 - $5,574
-49 Reduced 0.02%
226,950 $19.6 Million
Q4 2019

Feb 13, 2020
BUY
$86.8 - $118.57 $1.78 Million - $2.43 Million
20,464 Added 9.91%
226,999 $24.4 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $517,672 - $626,864
6,176 Added 3.08%
206,535 $18.6 Million
Q2 2019

Aug 13, 2019
BUY
$72.24 - $91.27 $1.07 Million - $1.35 Million
14,752 Added 7.95%
200,359 $16.9 Million
Q1 2019

May 14, 2019
SELL
$69.31 - $91.53 $35.1 Million - $46.3 Million
-506,244 Reduced 73.17%
185,607 $16.4 Million
Q4 2018

Feb 15, 2019
BUY
$68.32 - $124.36 $23 Million - $41.8 Million
336,101 Added 94.48%
691,851 $49.4 Million
Q3 2018

Nov 15, 2018
BUY
$98.88 - $125.85 $10 Million - $12.8 Million
101,517 Added 39.93%
355,750 $43.7 Million
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $213,400 - $300,375
2,834 Added 1.13%
254,233 $25 Million
Q1 2018

May 08, 2018
SELL
$75.88 - $92.43 $27,620 - $33,644
-364 Reduced 0.14%
251,399 $20.8 Million
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $48,579 - $64,399
-830 Reduced 0.33%
251,763 $19.5 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $12.1 Million - $15.5 Million
252,593
252,593 $15.5 Million

Others Institutions Holding NBIX

# of Institutions
653
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email